Hualiang Jiang

54.4k total citations · 9 hit papers
713 papers, 30.2k citations indexed

About

Hualiang Jiang is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Hualiang Jiang has authored 713 papers receiving a total of 30.2k indexed citations (citations by other indexed papers that have themselves been cited), including 433 papers in Molecular Biology, 177 papers in Organic Chemistry and 151 papers in Computational Theory and Mathematics. Recurrent topics in Hualiang Jiang's work include Computational Drug Discovery Methods (151 papers), Protein Structure and Dynamics (58 papers) and Chemical Synthesis and Analysis (48 papers). Hualiang Jiang is often cited by papers focused on Computational Drug Discovery Methods (151 papers), Protein Structure and Dynamics (58 papers) and Chemical Synthesis and Analysis (48 papers). Hualiang Jiang collaborates with scholars based in China, United States and Germany. Hualiang Jiang's co-authors include Kaixian Chen, Xiaomin Luo, Cheng Luo, Weiliang Zhu, Hong Liu, Mingyue Zheng, Honglin Li, Xu Shen, Jianhua Shen and Yechun Xu and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Hualiang Jiang

706 papers receiving 29.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting protein–protein interactions based only on sequences information

2007 745 citations Xiaomin Luo, Kaixian Chen et al. Proceedings of the National Academy of Sciences profile →
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach

2010 706 citations Honglin Li, Hualiang Jiang et al. Nucleic Acids Research profile →
Pushing the Boundaries of Molecular Representation for Drug Discovery with the Graph Attention Mechanism

2019 645 citations Zhaojun Li, Xiaomin Luo et al. Journal of Medicinal Chemistry profile →
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2

2010 615 citations Hualiang Jiang, Cheng Luo et al. Nature profile →
Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5

2014 555 citations Hualiang Jiang, Cheng Luo et al. Nucleic Acids Research profile →
Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex

2013 552 citations Qiuxiang Tan, Ya Zhu et al. Science profile →
Halogen Bonding—A Novel Interaction for Rational Drug Design?

2009 506 citations Huaiyu Yang, Hualiang Jiang et al. Journal of Medicinal Chemistry profile →
TransformerCPI: improving compound–protein interaction prediction by sequence-based deep learning with self-attention mechanism and label reversal experiments

2020 325 citations Xiaoqin Tan, Tianbiao Yang et al. Bioinformatics profile →
Structural insights into the lipid and ligand regulation of serotonin receptors

2021 185 citations Peiyu Xu, Sijie Huang et al. Nature profile →

Peers

Countries citing papers authored by Hualiang Jiang

Since Specialization

Citations

This map shows the geographic impact of Hualiang Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hualiang Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hualiang Jiang more than expected).

Fields of papers citing papers by Hualiang Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hualiang Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hualiang Jiang. The network helps show where Hualiang Jiang may publish in the future.

Co-authorship network of co-authors of Hualiang Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Hualiang Jiang. A scholar is included among the top collaborators of Hualiang Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hualiang Jiang. Hualiang Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concurrent inhibition of p300/CBP and FLT3 enhances cytotoxicity and overcomes resistance in acute myeloid leukemia 2025 ·Acta Pharmacologica Sinica ·Yujun Chen, Yu Zhao, (unknown), Wang Yf, Ming Ma, (unknown), Hualiang Jiang, Wei Wu, (unknown), Xiaowei Xu, Chengying Xie	1
2	Praseodymium dysprosium co-doped M-type strontium ferrite: Intentionally manufacturing heterophase growth to improve microwave absorption performance 2024 ·Materials Today Chemistry ·Xiaodong Jing, Zitao Chen, Qianqian Zhao, (unknown), (unknown), (unknown), Qun Wang, (unknown), Hualiang Jiang, (unknown), (unknown)	7
3	STING agonist-boosted mRNA immunization via intelligent design of nanovaccines for enhancing cancer immunotherapy 2023 ·National Science Review ·Lei Zhou, (unknown), Zehong Zhang, Xiaoting Shan, Zitong Zhao, Xiangshi Sun, Jue Wang, Hao Wang, Hualiang Jiang, Mingyue Zheng, Dangge Wang, Yaping Li	30
4	Identification of a carbohydrate recognition motif of purinergic receptors 2023 ·eLife ·(unknown), (unknown), Xinheng He, Antao Dai, Dehua Yang, Hualiang Jiang, Liuqing Wen, Xi Cheng	4
5	Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2 2021 ·Proceedings of the National Academy of Sciences ·(unknown), Xi Cheng, Lihua Zhao, Yuzhe Wang, Chenyu Ye, Xinyu Zou, Antao Dai, Zhaotong Cong, Jian Chen, Qingtong Zhou, Tian Xia, Hualiang Jiang, H. Eric Xu, Dehua Yang, Ming‐Wei Wang	25
6	Structural insights into the lipid and ligand regulation of serotonin receptors breakdown → 2021 ·Nature ·Peiyu Xu, Sijie Huang, Huibing Zhang, Chunyou Mao, X. Edward Zhou, Xi Cheng, Ícaro A. Simon, Dandan Shen, Hsin‐Yung Yen, Carol V. Robinson, Kasper Harpsøe, Bo Svensson, Jia Guo, Hualiang Jiang, David E. Gloriam, Karsten Melcher, Yi Jiang, Yan Zhang, H. Eric Xu	185
7	Mechanism of dopamine binding and allosteric modulation of the human D1 dopamine receptor 2021 ·Cell Research ·Youwen Zhuang, B. Krumm, Huibing Zhang, X. Edward Zhou, Yue Wang, Xi‐Ping Huang, Yongfeng Liu, Xi Cheng, Yi Jiang, Hualiang Jiang, Cheng Zhang, Wei Yi, Bryan L. Roth, Yan Zhang, H. Eric Xu	62
8	Structures of the human dopamine D3 receptor-Gi complexes 2021 ·Molecular Cell ·Peiyu Xu, Sijie Huang, Chunyou Mao, B. Krumm, X. Edward Zhou, Yangxia Tan, Xi‐Ping Huang, Yongfeng Liu, Dandan Shen, Yi Jiang, Xuekui Yu, Hualiang Jiang, Karsten Melcher, Bryan L. Roth, Xi Cheng, Yan Zhang, H. Eric Xu	57
9	Discovery of High-Affinity Inhibitors of the BPTF Bromodomain 2021 ·Journal of Medicinal Chemistry ·Tian Lu, Haibo Lu, Z. H. Duan, Jun Wang, Jie Han, Sen-Hao Xiao, (unknown), Hao Jiang, Yu Chen, Feng Yang, Qi Li, Dongying Chen, (unknown), Bo Li, Hualiang Jiang, Kaixian Chen, Wenchao Lu, Hua Lin, Cheng Luo	12
10	DrugSpaceX: a large screenable and synthetically tractable database extending drug space 2020 ·Nucleic Acids Research ·Tianbiao Yang, Zhaojun Li, Yingjia Chen, (unknown), Guangchao Wang, Zunyun Fu, Xiaoyu Ding, Xiaoqin Tan, Jihui Zhao, Xiaomin Luo, Kaixian Chen, Hualiang Jiang, Mingyue Zheng	26
11	p300/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization 2019 ·Theranostics ·(unknown), Jiacheng Li, Jing Huang, Pan Xu, (unknown), Y. Liu, Yu Liang, Yaxi Yang, (unknown), Hualiang Jiang, Kaixian Chen, Yongjun Dang, Yuanyuan Zhang, Cheng Luo, (unknown)	73
12	PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells 2017 ·Cancer Research ·(unknown), Zhen Gao, Dan Zhao, Lunfeng Zhang, Xinhua Qiao, Yingying Zhao, Hong Ding, Panpan Zhang, Junyan Lu, Jia Liu, Hualiang Jiang, Cheng Luo, Chang Chen	36
13	JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification 2015 ·Cancer Research ·Wenyi Sun, Zuoquan Xie, Yifu Liu, Dan Zhao, Zhixiang Wu, Dadong Zhang, Hao Lv, Shuai Tang, Nan Jin, Hualiang Jiang, Minjia Tan, Jian Ding, Cheng Luo, Jian Li, Min Huang, Meiyu Geng	69
14	Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex breakdown → 2013 ·Science ·Qiuxiang Tan, Ya Zhu, Jian Li, Zhuxi Chen, Gye Won Han, Irina Kufareva, Tingting Li, Limin Ma, Gustavo Fenalti, Jing Li, Wenru Zhang, Xin Xie, Huaiyu Yang, Hualiang Jiang, Vadim Cherezov, Hong Liu, Raymond C. Stevens, Qiang Zhao, Beili Wu	552
15	Highly Enantioselective Michael Addition of 2‐Oxindole‐ 3‐carboxylate Esters to Nitroolefins Promoted by Cinchona Alkaloid‐Thiourea‐Brønsted Acid Cocatalysts 2012 ·Advanced Synthesis & Catalysis ·Xianjie Chen, Wei Zhu, (unknown), Enguang Feng, Yu Zhou, Jinfang Wang, Hualiang Jiang, Zhu‐Jun Yao, Hong Liu	37
16	Iron Deprivation Suppresses Hepatocellular Carcinoma Growth in Experimental Studies 2011 ·Clinical Cancer Research ·Qian Ba, Miao Hao, He Huang, Junmei Hou, Shichao Ge, Zhuzhen Zhang, Jun Yin, Ruiai Chu, Hualiang Jiang, Fudi Wang, Kaixian Chen, Hong Liu, Hui Wang	56
17	[6]-Gingerol Suppresses Colon Cancer Growth by Targeting Leukotriene A4 Hydrolase 2009 ·Cancer Research ·Chul‐Ho Jeong, Ann M. Bode, Angelo Pugliese, Yong‐Yeon Cho, Hong-Gyum Kim, Jung‐Hyun Shim, Young-Jin Jeon, Honglin Li, Hualiang Jiang, Zigang Dong	149
18	DrugViz: a Cytoscape plugin for visualizing and analyzing small molecule drugs in biological networks 2008 ·Bioinformatics ·Bing Xiong, (unknown), Jie Wu, David L. Burk, Hualiang Jiang, Jingkang Shen	14
19	Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives 2007 ·Acta Pharmacologica Sinica ·Haihong Li, (unknown), Jinzhi Tan, Lili Chen, Hong Liu, Xiaomin Luo, Xu Shen, Liping Lin, Kaixian Chen, Jian Ding, Hualiang Jiang	14
20	Design, synthesis, antitumor evaluations and molecular modeling studies of novel 3,5-substituted indolin-2-one derivatives 2007 ·Acta Pharmacologica Sinica ·(unknown), (unknown), Jinzhi Tan, (unknown), Hong Liu, Xiaomin Luo, Xu Shen, Liping Lin, Kaixian Chen, Jian Ding, Hualiang Jiang	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact